|
1
|
Li H, Zheng RS, Zhang SW, Zeng HM, Sun XK,
Xia CF, Yang XZ, Chen WQ and He J: Incidence and mortality of
female breast cancer in china, 2014. Zhonghua Zhong Liu Za Zhi.
40:166–171. 2018.PubMed/NCBI
|
|
2
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG), ; Darby S, McGale P, Correa C, Taylor
C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, et al:
Effect of radiotherapy after breast-conserving surgery on 10-year
recurrence and 15-year breast cancer death: Meta-analysis of
individual patient data for 10,801 women in 17 randomised trials.
Lancet. 378:1707–1716. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
EBCTCG (Early Breast Cancer Trialists'
Collaborative Group), ; McGale P, Taylor C, Correa C, Cutter D,
Duane F, Ewertz M, Gray R, Mannu G, Peto R, et al: Effect of
radiotherapy after mastectomy and axillary surgery on 10-year
recurrence and 20-year breast cancer mortality: Meta-analysis of
individual patient data for 8135 women in 22 randomised trials.
Lancet. 383:2127–2135. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fisher B, Anderson S, Bryant J, Margolese
RG, Deutsch M, Fisher ER, Jeong JH and Wolmark N: Twenty-year
follow-up of a randomized trial comparing total mastectomy,
lumpectomy, and lumpectomy plus irradiation for the treatment of
invasive breast cancer. N Engl J Med. 47:1233–1241. 2002.
View Article : Google Scholar
|
|
5
|
Joubert A and Foray N: Intrinsic
radiosensitivity and DNA double-strand breaks in human cells.
Cancer Radiother. 11:129–142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barker HE, Paget JT, Khan AA and
Harrington KJ: The tumour microenvironment after radiotherapy:
Mechanisms of resistance and recurrence. Nat Rev Cancer.
15:409–425. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marples B and Collis SJ: Low-dose
hyper-radiosensitivity: Past, present, and future. Int J Radiat
Oncol Biol Phys. 70:1310–1318. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhivotovsky B, Joseph B and Orrenius S:
Tumor radiosensitivity and apoptosis. Exp Cell Res. 248:10–17.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pawlik TM and Keyomarsi K: Role of cell
cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol
Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meng J, Li P, Zhang Q, Yang Z and Fu S: A
radiosensitivity gene signature in predicting glioma prognostic via
EMT pathway. Oncotarget. 5:4683–4693. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anzai E, Hirata K, Shibazaki M, Yamada C,
Morii M, Honda T and Yamaguchi N and Yamaguchi N: FOXA1 induces
E-cadherin expression at the protein level via suppression of slug
in epithelial Breast cancer cells. Biol Pharm Bull. 40:1483–1489.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Canel M, Serrels A, Frame MC and Brunton
VG: E-cadherin-integrin crosstalk in cancer invasion and
metastasis. J Cell Sci. 126:393–401. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hou J, Zhou Z, Chen X, Zhao R, Yang Z, Wei
N, Ni Q, Feng Y, Yu X, Ma J and Guo X: HER2 reduces breast cancer
radiosensitivity by activating focal adhesion kinase in vitro and
in vivo. Oncotarget. 7:45186–45198. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. Nat
Genet. 25:25–29. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
The Gene Ontology Consortium: The gene
ontology resource: 20 years and still GOing strong. Nucleic Acids
Res. 47:D330–D338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kanehisa M, Sato Y, Furumichi M, Morishima
K and Tanabe M: New approach for understanding genome variations in
KEGG. Nucleic Acids Res. 47:D590–D595. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou J, Wang Z, Xu H, Yang L, Yu X, Yang Z,
Deng Y, Meng J, Feng Y, Guo X and Yang G: Stanniocalicin 2
suppresses breast cancer cell migration and invasion via the
PKC/claudin-1-mediated signaling. PLoS One. 10:e1221792015.
|
|
20
|
Santamaría PG, Moreno-Bueno G and Cano A:
Contribution of Epithelial plasticity to therapy resistance. J Clin
Med. 8:6762019. View Article : Google Scholar
|
|
21
|
Xie P, Yu H, Wang F, Yan F and He X:
Inhibition of LOXL2 enhances the radiosensitivity of
castration-resistant prostate cancer cells associated with the
reversal of the EMT process. BioMed Res Int. 27:40125902019.
|
|
22
|
Fischer KR, Durrans A, Lee S, Sheng J, Li
F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, et al:
Epithelial-to-mesenchymal transition is not required for lung
metastasis but contributes to chemoresistance. Nature. 527:472–476.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cordes N and Meineke V: Cell
adhesion-mediated radioresistance (CAM-RR). Extracellular
matrix-dependent improvement of cell survival in human tumor and
normal cells in vitro. Strahlenther Onkol. 179:337–344. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cordes N, Frick S, Brunner TB, Pilarsky C,
Grützmann R, Sipos B, Klöppel G, McKenna WG and Bernhard EJ: Human
pancreatic tumor cells are sensitized to ionizing radiation by
knockdown of caveolin-1. Oncogene. 26:6851–6862. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beinke C, Van Beuningen D and Cordes N:
Ionizing radiation modules of the expression and tyrosine
phosphorylation of the focal adhesion-associated proteins focal
adhesion kinase (FAK) and its substrates p130cas and paxillin in
A549 human lung carcinoma cells in vitro. Int J Radiat Biol.
79:721–731. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Braren R, Hu H, Kim YH, Beggs HE,
Reichardt LF and Wang R: Endothelial FAK is essential for vascular
network stability, cell survival, and lamellipodial formation. J
Cell Biol. 172:151–162. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hanks SK, Ryzhova L, Shin NY and Brábek J:
Focal adhesion kinase signaling activities and their implications
in the control of cell survival and motility. Front Biosci.
8:d982–d996. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chan KT, Cortesio CL and Huttenlocher A:
FAK alters invadopodia and focal adhesion composition and dynamics
to regulate breast cancer invasion. J Cell Biol. 185:357–370. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han EK, Mcgonigal T, Wang J, Giranda VL
and Luo Y: Functional analysis of focal adhesion kinase (FAK)
reduction by small inhibitory RNAs. Anticancer Res. 24:3899–3905.
2004.PubMed/NCBI
|
|
30
|
Sulzmaier FJ, Jean C and Schlaepfer DD:
FAK in cancer: Mechanistic findings and clinical applications. Nat
Rev Cancer. 14:598–610. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li JJ, Tu WZ, Chen XM, Ying HY, Chen Y, Ge
YL, Wang J, Xu Y, Chen TF, Zhang XW, et al: FAK alleviates
radiation-induced rectal injury by decreasing apoptosis. Toxicol
Appl Pharmacol. 360:131–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang C, Deng X, Qiu L, Peng F, Geng S,
Shen L and Luo Z: Knockdown of C1GalT1 inhibits radioresistance of
human esophageal cancer cells through modifying β1-integrin
glycosylation. J Cancer. 9:2666–2677. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cicchini C, Laudadio I, Citarella F,
Corazzari M, Steindler C, Conigliaro A, Fantoni A, Amicone L and
Tripodi M: TGFbeta-induced EMT requires focal adhesion kinase (FAK)
signaling. Exp Cell Res. 314:143–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Graham K, Moran-Jones K, Sansom OJ,
Brunton VG and Frame MC: FAK deletion promotes p53-mediated
induction of p21, DNA-damage responses and radio-resistance in
advanced squamous cancer cells. PLoS One. 6:e278062011. View Article : Google Scholar : PubMed/NCBI
|
